Whether the conversation is about FDA’s proposal for mandatory product listing (MPL), creating a pathway to market for CBD or adopting broader reforms for how dietary supplements are regulated, the industry is faced with plenty of divisive policy issues today.
On Tuesday, April 18, at SupplySide East in Secaucus, New Jersey, I have the pleasure of moderating a panel that comprises five regulatory and legal experts, including the head of FDA’s Office of Dietary Supplement Programs, Cara Welch, Ph.D.
Other speakers include naturopathic doctor Duffy MacKay of the Consumer Healthcare Products Association (CHPA) and lawyers Megan Olsen of the Council for Responsible Nutrition (CRN), Rend Al-Mondhiry of Amin Talati Wasserman LLP and Kevin Bell of Arnall Golden Gregory LLP, who also is outside counsel to the Natural Products Association (NPA).
Here’s the format for the one-hour discussion.
I’ll present a few slides from a 2023 regulatory survey that was a project of SupplySide and Natural Products Insider, conducted in collaboration with New Hope Networks’ NEXT custom research team. The results include awareness and support of MPL, legislative priorities for the industry and how stakeholders feel about FDA enforcement of the Dietary Supplement Health and Education Act of 1994 (DSHEA).
Next, I’ll turn it over to Dr. Welch for a short presentation, followed by comments and analysis from our other speakers who are deeply entrenched in regulatory issues.
The second half of the hour will be devoted to answering questions from the audience. I’m happy to hand over the mic if you have a question for Dr. Welch or our other experts.
Just be sure to show up for the event. I look forward to seeing you there.
Josh